Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Contribution of a haplotype in the HLA region to anti-cyclic citrullinated peptide antibody positivity in rheumatoid arthritis, independently of HLA-DRB1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP69622.RA2xosSS9ddZndBkkfBumiVWfMzkXL0hF2BvL_nb6V68A130_assertion description "[Contribution of a haplotype in the HLA region to anti-cyclic citrullinated peptide antibody positivity in rheumatoid arthritis, independently of HLA-DRB1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP69622.RA2xosSS9ddZndBkkfBumiVWfMzkXL0hF2BvL_nb6V68A130_provenance.
• NP79427.RA35F35WzFwOhX3svN2cSvpptFZyykg6Ej9YREgIaoTs4130_assertion description "[Contribution of a haplotype in the HLA region to anti-cyclic citrullinated peptide antibody positivity in rheumatoid arthritis, independently of HLA-DRB1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP79427.RA35F35WzFwOhX3svN2cSvpptFZyykg6Ej9YREgIaoTs4130_provenance.
• NP79418.RAX7y5_eH0p6lnRJDJzD8FYrJJuwhbv9VzLcmzReY23Ws130_assertion description "[Contribution of a haplotype in the HLA region to anti-cyclic citrullinated peptide antibody positivity in rheumatoid arthritis, independently of HLA-DRB1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP79418.RAX7y5_eH0p6lnRJDJzD8FYrJJuwhbv9VzLcmzReY23Ws130_provenance.
• NP74423.RA83QsoiBybi5xJmMvna6kNDNXszYPE7WIogbSkfRkHGU130_assertion description "[Contribution of a haplotype in the HLA region to anti-cyclic citrullinated peptide antibody positivity in rheumatoid arthritis, independently of HLA-DRB1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP74423.RA83QsoiBybi5xJmMvna6kNDNXszYPE7WIogbSkfRkHGU130_provenance.
• NP62956.RAn4UylU8WpH-EEBtsv3P-bDSLbPphhnEQUGOSD-T6TZg130_assertion description "[Contribution of a haplotype in the HLA region to anti-cyclic citrullinated peptide antibody positivity in rheumatoid arthritis, independently of HLA-DRB1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP62956.RAn4UylU8WpH-EEBtsv3P-bDSLbPphhnEQUGOSD-T6TZg130_provenance.
• NP67995.RAhWmd9pGPKk1xRLGY6KgY242MhmK1hr4MCQlx67jIgMA130_assertion description "[Contribution of a haplotype in the HLA region to anti-cyclic citrullinated peptide antibody positivity in rheumatoid arthritis, independently of HLA-DRB1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP67995.RAhWmd9pGPKk1xRLGY6KgY242MhmK1hr4MCQlx67jIgMA130_provenance.
• NP68755.RAOx4qh-nJxqyvA9t7PzMJEGkMmjhQtm3_V3IA2n1m4AA130_assertion description "[Contribution of a haplotype in the HLA region to anti-cyclic citrullinated peptide antibody positivity in rheumatoid arthritis, independently of HLA-DRB1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP68755.RAOx4qh-nJxqyvA9t7PzMJEGkMmjhQtm3_V3IA2n1m4AA130_provenance.
• NP73567.RAmadxGzmaAHLqE4jX9mLtuaUO4WPSTV7tFjncUIeZtMk130_assertion description "[Contribution of a haplotype in the HLA region to anti-cyclic citrullinated peptide antibody positivity in rheumatoid arthritis, independently of HLA-DRB1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP73567.RAmadxGzmaAHLqE4jX9mLtuaUO4WPSTV7tFjncUIeZtMk130_provenance.
• NP79411.RAh_w8vk8nq-LA_eFX2daDIt0ldcDWzz6lSMdOvszxJY4130_assertion description "[Contribution of a haplotype in the HLA region to anti-cyclic citrullinated peptide antibody positivity in rheumatoid arthritis, independently of HLA-DRB1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP79411.RAh_w8vk8nq-LA_eFX2daDIt0ldcDWzz6lSMdOvszxJY4130_provenance.
• NP79428.RANVV29fjRTB7Lb1n2UJllkreDzPfLbEtrX2W6ZyurWVg130_assertion description "[Contribution of a haplotype in the HLA region to anti-cyclic citrullinated peptide antibody positivity in rheumatoid arthritis, independently of HLA-DRB1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP79428.RANVV29fjRTB7Lb1n2UJllkreDzPfLbEtrX2W6ZyurWVg130_provenance.
• assertion description "[Contribution of a haplotype in the HLA region to anti-cyclic citrullinated peptide antibody positivity in rheumatoid arthritis, independently of HLA-DRB1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Contribution of a haplotype in the HLA region to anti-cyclic citrullinated peptide antibody positivity in rheumatoid arthritis, independently of HLA-DRB1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP89761.RARQmeUPz5q0M-hHw3TCLl16IDeDMzmlb0fRtjva-MAwo130_assertion description "[Contribution of a haplotype in the HLA region to anti-cyclic citrullinated peptide antibody positivity in rheumatoid arthritis, independently of HLA-DRB1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP89761.RARQmeUPz5q0M-hHw3TCLl16IDeDMzmlb0fRtjva-MAwo130_provenance.
• NP118578.RAf92x4Ovd6NmMswTx_JcF4g7OsarEPN3KXOTyrmnH0pE130_assertion description "[Contribution of a haplotype in the HLA region to anti-cyclic citrullinated peptide antibody positivity in rheumatoid arthritis, independently of HLA-DRB1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP118578.RAf92x4Ovd6NmMswTx_JcF4g7OsarEPN3KXOTyrmnH0pE130_provenance.
• NP118622.RASGJN5fckqabZprard3fS4UIK-9Xhic_l5WokZVI0w8s130_assertion description "[Contribution of a haplotype in the HLA region to anti-cyclic citrullinated peptide antibody positivity in rheumatoid arthritis, independently of HLA-DRB1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP118622.RASGJN5fckqabZprard3fS4UIK-9Xhic_l5WokZVI0w8s130_provenance.
• assertion description "[Contribution of a haplotype in the HLA region to anti-cyclic citrullinated peptide antibody positivity in rheumatoid arthritis, independently of HLA-DRB1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Contribution of a haplotype in the HLA region to anti-cyclic citrullinated peptide antibody positivity in rheumatoid arthritis, independently of HLA-DRB1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Contribution of a haplotype in the HLA region to anti-cyclic citrullinated peptide antibody positivity in rheumatoid arthritis, independently of HLA-DRB1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Contribution of a haplotype in the HLA region to anti-cyclic citrullinated peptide antibody positivity in rheumatoid arthritis, independently of HLA-DRB1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Contribution of a haplotype in the HLA region to anti-cyclic citrullinated peptide antibody positivity in rheumatoid arthritis, independently of HLA-DRB1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Contribution of a haplotype in the HLA region to anti-cyclic citrullinated peptide antibody positivity in rheumatoid arthritis, independently of HLA-DRB1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Contribution of a haplotype in the HLA region to anti-cyclic citrullinated peptide antibody positivity in rheumatoid arthritis, independently of HLA-DRB1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP160943.RAVLa8ya_Pz_lXrAkP11xK392S87hirQG6uIqwCWThKnU130_assertion description "[Contribution of a haplotype in the HLA region to anti-cyclic citrullinated peptide antibody positivity in rheumatoid arthritis, independently of HLA-DRB1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP160943.RAVLa8ya_Pz_lXrAkP11xK392S87hirQG6uIqwCWThKnU130_provenance.
• NP160946.RAbmxusshqtUTUiziixlEdCTMtXnYRR6-LxNYUKo0RSMY130_assertion description "[Contribution of a haplotype in the HLA region to anti-cyclic citrullinated peptide antibody positivity in rheumatoid arthritis, independently of HLA-DRB1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP160946.RAbmxusshqtUTUiziixlEdCTMtXnYRR6-LxNYUKo0RSMY130_provenance.
• NP160949.RAQf3_Od_He5wKFvfuOBWYXiI3Ut4ruNXxtGPOKIkMkfA130_assertion description "[Contribution of a haplotype in the HLA region to anti-cyclic citrullinated peptide antibody positivity in rheumatoid arthritis, independently of HLA-DRB1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP160949.RAQf3_Od_He5wKFvfuOBWYXiI3Ut4ruNXxtGPOKIkMkfA130_provenance.
• NP88121.RAvWGGZSlpU1WiM6bsslVm6zbBhzoGDY6XjmFK9NZuKhw130_assertion description "[Contribution of a haplotype in the HLA region to anti-cyclic citrullinated peptide antibody positivity in rheumatoid arthritis, independently of HLA-DRB1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP88121.RAvWGGZSlpU1WiM6bsslVm6zbBhzoGDY6XjmFK9NZuKhw130_provenance.
• NP92296.RAmEjEO2wfLjEzdd6qpnPh984vNghqpzLp5ew8CvYNg8Y130_assertion description "[Contribution of a haplotype in the HLA region to anti-cyclic citrullinated peptide antibody positivity in rheumatoid arthritis, independently of HLA-DRB1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP92296.RAmEjEO2wfLjEzdd6qpnPh984vNghqpzLp5ew8CvYNg8Y130_provenance.
• assertion description "[Contribution of a haplotype in the HLA region to anti-cyclic citrullinated peptide antibody positivity in rheumatoid arthritis, independently of HLA-DRB1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Contribution of a haplotype in the HLA region to anti-cyclic citrullinated peptide antibody positivity in rheumatoid arthritis, independently of HLA-DRB1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP160944.RACOxFXABRUs79UO_LU3h5vbH75Ryc5ErqYXn63Tk0K6c130_assertion description "[Contribution of a haplotype in the HLA region to anti-cyclic citrullinated peptide antibody positivity in rheumatoid arthritis, independently of HLA-DRB1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP160944.RACOxFXABRUs79UO_LU3h5vbH75Ryc5ErqYXn63Tk0K6c130_provenance.
• NP63177.RA86-kXbwSL3PR-lRF1-jdPeI6KpWNAJhYnMpVxJtXmVk130_assertion description "[Contribution of a haplotype in the HLA region to anti-cyclic citrullinated peptide antibody positivity in rheumatoid arthritis, independently of HLA-DRB1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP63177.RA86-kXbwSL3PR-lRF1-jdPeI6KpWNAJhYnMpVxJtXmVk130_provenance.
• NP160941.RAvLNSiWNLv7kb73mg1aMn0hT2tlR6tpQ8Y3uJbN2bL-o130_assertion description "[Contribution of a haplotype in the HLA region to anti-cyclic citrullinated peptide antibody positivity in rheumatoid arthritis, independently of HLA-DRB1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP160941.RAvLNSiWNLv7kb73mg1aMn0hT2tlR6tpQ8Y3uJbN2bL-o130_provenance.
• NP160947.RAkrquVTcQCKzm5Q9fCB7ITEy3jbdHZjxebLOOj3_aAjg130_assertion description "[Contribution of a haplotype in the HLA region to anti-cyclic citrullinated peptide antibody positivity in rheumatoid arthritis, independently of HLA-DRB1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP160947.RAkrquVTcQCKzm5Q9fCB7ITEy3jbdHZjxebLOOj3_aAjg130_provenance.
• NP160950.RAr7UBmNiJ29-IChlve3zxg2_dQF1VjKfIuSYuMLAtiwY130_assertion description "[Contribution of a haplotype in the HLA region to anti-cyclic citrullinated peptide antibody positivity in rheumatoid arthritis, independently of HLA-DRB1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP160950.RAr7UBmNiJ29-IChlve3zxg2_dQF1VjKfIuSYuMLAtiwY130_provenance.
• NP81658.RA5J4JZXfruuymKZVjtBYOLCmQzDLjJRqLkmFma59sp0c130_assertion description "[Contribution of a haplotype in the HLA region to anti-cyclic citrullinated peptide antibody positivity in rheumatoid arthritis, independently of HLA-DRB1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP81658.RA5J4JZXfruuymKZVjtBYOLCmQzDLjJRqLkmFma59sp0c130_provenance.
• NP118592.RA_rETgcGFG5EJO9M-E_k7URt3UKsWeMVi3QlNaJG8sao130_assertion description "[Contribution of a haplotype in the HLA region to anti-cyclic citrullinated peptide antibody positivity in rheumatoid arthritis, independently of HLA-DRB1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP118592.RA_rETgcGFG5EJO9M-E_k7URt3UKsWeMVi3QlNaJG8sao130_provenance.
• NP103553.RALktFLirtmXCderZ-Diq2AFEoJleTgqWNktZGo57A2DY130_assertion description "[Contribution of a haplotype in the HLA region to anti-cyclic citrullinated peptide antibody positivity in rheumatoid arthritis, independently of HLA-DRB1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP103553.RALktFLirtmXCderZ-Diq2AFEoJleTgqWNktZGo57A2DY130_provenance.
• NP118618.RAL2g0bd7wZ0PTIavqZ86bRP29QhNi_mmUOtT4HEsYMUI130_assertion description "[Contribution of a haplotype in the HLA region to anti-cyclic citrullinated peptide antibody positivity in rheumatoid arthritis, independently of HLA-DRB1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP118618.RAL2g0bd7wZ0PTIavqZ86bRP29QhNi_mmUOtT4HEsYMUI130_provenance.
• NP160942.RAO8UYE-uX85OODz0G4DAsCy0nlENDeijtvWg-h2zpaaI130_assertion description "[Contribution of a haplotype in the HLA region to anti-cyclic citrullinated peptide antibody positivity in rheumatoid arthritis, independently of HLA-DRB1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP160942.RAO8UYE-uX85OODz0G4DAsCy0nlENDeijtvWg-h2zpaaI130_provenance.
• NP160940.RA_Li18VDeTEv5-eO3Tqb0HxExSuBz3FzwYFyIl8xsE9g130_assertion description "[Contribution of a haplotype in the HLA region to anti-cyclic citrullinated peptide antibody positivity in rheumatoid arthritis, independently of HLA-DRB1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP160940.RA_Li18VDeTEv5-eO3Tqb0HxExSuBz3FzwYFyIl8xsE9g130_provenance.
• NP160945.RA3rEsNF7-OlyS5mV1StBkJhDGJ5byCxTXC3Yg7qMs9Qk130_assertion description "[Contribution of a haplotype in the HLA region to anti-cyclic citrullinated peptide antibody positivity in rheumatoid arthritis, independently of HLA-DRB1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP160945.RA3rEsNF7-OlyS5mV1StBkJhDGJ5byCxTXC3Yg7qMs9Qk130_provenance.
• NP160948.RA5EHEWvc_tLcoxr99lz5dUbVORxOj-gwBb354QHjgDNg130_assertion description "[Contribution of a haplotype in the HLA region to anti-cyclic citrullinated peptide antibody positivity in rheumatoid arthritis, independently of HLA-DRB1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP160948.RA5EHEWvc_tLcoxr99lz5dUbVORxOj-gwBb354QHjgDNg130_provenance.